Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide in Moderate Severity Parkinson's Disease
NCT01971242Phase 2Completed
- Sponsor
- University College London
- Start
- Jun 2014
- Primary completion
- May 2016
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of exenatide in Parkinson's disease (PD), sponsored by University College London. Started Jun 2014; status: completed.
02
Drugs
exenatide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01971242.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01971242.